Keyphrases
COVID-19
100%
Hospitalization
80%
Neurologic Symptoms
50%
Healthcare Utilization
50%
Growth Hormone Treatment
50%
Pulmonary Embolism
30%
SARS-CoV-2 Infection
27%
Sleep Quality
27%
Control pilot
25%
Post-COVID-19 Recovery
25%
Post-acute Sequelae SARS-CoV-2 Infection
25%
Oscillometry
25%
Cause of Death
25%
Delta Variant
25%
Poor Sleep
25%
Reinfection
25%
Post-coronavirus
25%
Coronavirus Disease (COVID)
25%
Hypertensive Disorders of Pregnancy
25%
Mental Health
25%
Vaccination
25%
Omicron Variant
25%
Pulmonary Hypertension
25%
COVID-19 Infection
25%
Low Growth
25%
COVID-19 Pandemic
25%
Chronic Obstructive Pulmonary Disease
25%
Infection-induced Immunity
25%
Posttraumatic Stress
25%
Post-acute Sequelae of COVID-19 (PASC)
25%
Chronic Respiratory Diseases
25%
Multidisciplinary Approach
25%
Pulmonary Embolism Response Team
25%
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
20%
Pregnant Women
20%
Hybrid Immunity
16%
Biomedical Parameters
16%
Insomnia
16%
Anxiety-depression
16%
Pre-existing Immunity
16%
Pulmonary Arterial Hypertension
15%
Intensive Care Unit
14%
Confidence Interval
13%
Relative Risk
13%
Emergency Department
11%
Rate Ratio
11%
Pulmonary Medicine
11%
Initial Infection
10%
University of Texas
10%
Length of Stay
10%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
81%
COVID-19
71%
Infection
61%
Neurologic Disease
50%
Sequela
50%
Gestational Hypertension
50%
Pulmonary Hypertension
50%
Growth Hormone Release
39%
Chronic Obstructive Pulmonary Disease
29%
Pulmonary Embolism
28%
Growth Hormone
25%
Coronavirinae
25%
Oscillometry
25%
Chronic Respiratory Tract Disease
25%
Omicron Coronavirus Variant
25%
Reinfection
25%
Pulmonary Embolism Response Team
25%
Lung
16%
Chronic Thromboembolic Pulmonary Hypertension
14%
Physical Performance
10%
Hybrid Immunity
10%
Intensive Care Unit
8%
Disease
8%
Spirometry
8%
Clinical Trial
7%
Acute Pulmonary Embolism
7%
Dyspnea
7%
Cardiac Catheterization
7%
Heart Right Ventricle Failure
6%
Quality of Life
5%
Intensivist
5%
Transthoracic Echocardiography
5%
Warfarin
5%
Comorbidity
5%
Public Health
5%
Virus Nucleocapsid
5%
Health Hazard
5%